Data from the Hong Kong Stock Exchange reveals that from September 2 to 3, Chairman and Chief Executive Officer Zhu Zhongyuan increased his stake in 映恩生物-B (09606) on two successive trading days.
The total acquisition amounted to 20,000 shares at an average price of approximately HK$179.10 per share, with a combined transaction value of around HK$3.582 million.
Following this purchase, Zhu's latest shareholding stands at approximately 16.0397 million shares, representing a 17.58% ownership stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments